Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein Barr virus encoded latent membrane protein 1.

Song X, Tao Y, Tan Y, Lee LM, Deng X, Wu Q, Cao Y.

Sci China C Life Sci. 2005 Feb;48(1):70-80.

PMID:
15844359
2.

Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.

Song X, Tao YG, Deng XY, Jin X, Tan YN, Tang M, Wu Q, Lee LM, Cao Y.

Cell Signal. 2004 Oct;16(10):1153-62.

PMID:
15240010
3.

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

Liu H, Zheng H, Duan Z, Hu D, Li M, Liu S, Li Z, Deng X, Wang Z, Tang M, Shi Y, Yi W, Cao Y.

Mol Cancer. 2009 Oct 27;8:92. doi: 10.1186/1476-4598-8-92.

5.
6.
7.
8.

Epstein-Barr virus-encoded latent membrane protein 1 modulates cyclin D1 by c-Jun/Jun B heterodimers.

Song X, Tao Y, Zeng L, Yang J, Tang F, Lee LM, Gong J, Wu Q, Cao Y.

Sci China C Life Sci. 2005 Aug;48(4):385-93.

PMID:
16248432
9.
10.

EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.

Chang PY, Wu ZZ, Sun NK, Chao CC.

J Cell Physiol. 2014 Mar;229(3):309-22. doi: 10.1002/jcp.24448.

PMID:
23939952
11.

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.

Kieser A, Kilger E, Gires O, Ueffing M, Kolch W, Hammerschmidt W.

EMBO J. 1997 Nov 3;16(21):6478-85.

12.

Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.

Lo AK, Dawson CW, Young LS, Ko CW, Hau PM, Lo KW.

J Pathol. 2015 Oct;237(2):238-48. doi: 10.1002/path.4575. Epub 2015 Aug 3.

PMID:
26096068
13.

Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.

Zheng H, Li LL, Hu DS, Deng XY, Cao Y.

Cell Mol Immunol. 2007 Jun;4(3):185-96. Review.

14.

Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells.

Sung WW, Chu YC, Chen PR, Liao MH, Lee JW.

Cancer Lett. 2016 Nov 1;382(1):21-31. doi: 10.1016/j.canlet.2016.08.021. Epub 2016 Aug 24.

PMID:
27567526
15.

[Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells].

Wang C, Deng X, Li X, Gu H, Yi W, Weng X, Xia L, Cao Y.

Zhonghua Zhong Liu Za Zhi. 2002 Jan;24(1):9-13. Chinese.

PMID:
11977651
16.
17.

EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.

Liu H, Duan Z, Zheng H, Hu D, Li M, Tao Y, Bode AM, Dong Z, Cao Y.

PLoS One. 2012;7(3):e32624. doi: 10.1371/journal.pone.0032624. Epub 2012 Mar 1.

18.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
19.

Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1.

Tao Y, Song X, Deng X, Xie D, Lee LM, Liu Y, Li W, Li L, Deng L, Wu Q, Gong J, Cao Y.

Exp Cell Res. 2005 Feb 15;303(2):240-51. Epub 2004 Nov 11.

PMID:
15652339
20.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217

Supplemental Content

Support Center